Ursprung des Netzwerks ersten Grades von Danny Joh
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Danny Joh
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ABBVIE INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Doctorate Degree | |
| Royal Institute of Technology | College/University | Doctorate Degree | |
| Universität des Saarlandes | College/University | Doctorate Degree | |
Eleva GmbH
 Eleva GmbH BiotechnologyHealth Technology Eleva GmbH develops biotechnology products and services. It offers Moss-aGal, Moss-GBA, Moss-FH, contract development and production, developmental pipeline, and technology transfer. The company was founded by Ralf Reski and Gunther Neuhaus in 1999 and is headquartered in Heilbronn, Germany. | Biotechnology | Chief Executive Officer | |
Isogenica Ltd.
 Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Isogenica Ltd. provides research and development services in the fields of new peptide, antibody and other polypeptide drug candidates. It offers llamdA System, Xab System and 4D Fab System. The company was founded by Kevin Fitzgerald in 2000 and is headquartered in Little Chesterford, the United Kingdom. | Miscellaneous Commercial Services | Chairman | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chairman | |
| GENSCRIPT BIOTECH CORPORATION | Biotechnology | Corporate Officer/Principal | |
Atriva Therapeutics GmbH
 Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | Biotechnology | Corporate Officer/Principal | |
Sapreme Technologies BV
 Sapreme Technologies BV BiotechnologyHealth Technology Sapreme Technologies BV operates as a biotech company that develops a platform technology to enable cytosolic delivery of macromolecule therapeutics. The company was founded by Ruben Postel in 2016 and is headquartered in Utrecht, the Netherlands. | Biotechnology | Chairman | |
| Neurocode Labs, Inc. | Chief Tech/Sci/R&D Officer | ||
Ciliatech Therapeutics AG
 Ciliatech Therapeutics AG Pharmaceuticals: MajorHealth Technology Ciliatech Therapeutics AG is a Swiss company that focuses on researching, developing, producing, and distributing pharmaceutical and diagnostic products. | Pharmaceuticals: Major | Chief Executive Officer | |
| Medraxa Therapeutics GmbH | Chief Executive Officer | ||
| BC Biomed Consulting GmbH | Chief Executive Officer |
Statistik
International
| Deutschland | 6 |
| Schweden | 4 |
| Schweiz | 3 |
| Vereinigte Staaten | 2 |
| Norwegen | 2 |
Sektoral
| Health Technology | 9 |
| Consumer Services | 4 |
| Commercial Services | 3 |
| Finance | 2 |
Operativ
| Chief Executive Officer | 4 |
| Chairman | 4 |
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 3 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Björn Cochlovius | 14 |
| Hans Frykman | 4 |
| Berkan Unal | 2 |
